Barr E S & Co Has Lowered Goldman Sachs Grp (GS) Position, Glycomimetics Has 1.79 Sentiment

June 20, 2017 - By Dolores Ford

GlycoMimetics, Inc. is a clinical-stage biotechnology company. The company has market cap of $381.00 million. The Firm focuses on the discovery and development of glycomimetic drugs. It currently has negative earnings. The Firm operates through the identification and development of glycomimetic compounds segment.

Barr E S & Co decreased Goldman Sachs Grp Inc (GS) stake by 3.06% reported in 2016Q4 SEC filing. Barr E S & Co sold 5,544 shares as Goldman Sachs Grp Inc (GS)’s stock declined 13.97%. The Barr E S & Co holds 175,364 shares with $41.99 million value, down from 180,908 last quarter. Goldman Sachs Grp Inc now has $90.52 billion valuation. The stock declined 0.25% or $0.56 reaching $225.57 per share. About 915,436 shares traded. Goldman Sachs Group Inc (NYSE:GS) has risen 39.23% since June 20, 2016 and is uptrending. It has outperformed by 22.53% the S&P500.

Investors sentiment increased to 0.88 in Q4 2016. Its up 0.02, from 0.86 in 2016Q3. It increased, as 65 investors sold GS shares while 424 reduced holdings. 168 funds opened positions while 262 raised stakes. 287.95 million shares or 5.61% more from 272.65 million shares in 2016Q3 were reported. Aqr Capital Mgmt Ltd holds 342,535 shares or 0.11% of its portfolio. Old Natl Bank In invested in 1.13% or 82,124 shares. Burke & Herbert Bancshares & holds 1,847 shares. Cetera Advsr Limited Liability Corporation holds 0.09% of its portfolio in Goldman Sachs Group Inc (NYSE:GS) for 4,950 shares. Ruane Cunniff And Goldfarb invested in 715,555 shares or 1.61% of the stock. Riverpoint Cap Mgmt Llc invested in 853 shares or 0.02% of the stock. Mercer Cap Advisers Inc, a New Jersey-based fund reported 766 shares. Assets Mngmt Ltd Company stated it has 1.84% of its portfolio in Goldman Sachs Group Inc (NYSE:GS). Moreover, Yacktman Asset Mngmt LP has 0.39% invested in Goldman Sachs Group Inc (NYSE:GS). Cwm Limited Liability has 0.01% invested in Goldman Sachs Group Inc (NYSE:GS) for 381 shares. British Columbia Corp, a British Columbia – Canada-based fund reported 162,876 shares. Pictet North America Advisors Sa has 0.06% invested in Goldman Sachs Group Inc (NYSE:GS) for 1,200 shares. Advantus Management Incorporated has invested 0.24% in Goldman Sachs Group Inc (NYSE:GS). Lba Wealth Management Ltd Liability, Florida-based fund reported 317 shares. Hartwell J M Partnership holds 0.18% in Goldman Sachs Group Inc (NYSE:GS) or 3,000 shares.

Since January 19, 2017, it had 0 insider buys, and 16 sales for $38.08 million activity. 32,325 shares valued at $8.08M were sold by ROGERS JOHN F.W. on Tuesday, February 14. SALAME PABLO J had sold 10,000 shares worth $2.52M. $1.99M worth of Goldman Sachs Group Inc (NYSE:GS) shares were sold by COOPER EDITH W. 2,384 shares were sold by COHEN ALAN M, worth $571,767 on Friday, February 3. SCHWARTZ HARVEY M had sold 25,000 shares worth $5.85M. Another trade for 6,250 shares valued at $1.50M was sold by SOLOMON DAVID M. $2.51 million worth of Goldman Sachs Group Inc (NYSE:GS) shares were sold by SMITH SARAH G.

Among 26 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 15 have Buy rating, 1 Sell and 10 Hold. Therefore 58% are positive. Goldman Sachs Group Inc. had 60 analyst reports since July 21, 2015 according to SRatingsIntel. On Tuesday, November 29 the stock rating was downgraded by Nomura to “Neutral”. Citigroup downgraded Goldman Sachs Group Inc (NYSE:GS) on Tuesday, November 8 to “Neutral” rating. The rating was maintained by Deutsche Bank with “Hold” on Wednesday, August 12. Citigroup upgraded Goldman Sachs Group Inc (NYSE:GS) on Wednesday, April 19 to “Neutral” rating. RBC Capital Markets maintained the shares of GS in report on Wednesday, July 20 with “Sector Perform” rating. The stock has “Outperform” rating by Wood on Friday, April 7. Vetr upgraded it to “Buy” rating and $212.64 target in Monday, August 24 report. On Tuesday, February 16 the stock rating was upgraded by JP Morgan to “Overweight”. The stock of Goldman Sachs Group Inc (NYSE:GS) has “Buy” rating given on Monday, October 17 by Rafferty. The company was upgraded on Monday, January 25 by Nomura.

Analysts await Goldman Sachs Group Inc (NYSE:GS) to report earnings on July, 18. They expect $3.98 earnings per share, up 6.99% or $0.26 from last year’s $3.72 per share. GS’s profit will be $1.60B for 14.17 P/E if the $3.98 EPS becomes a reality. After $5.15 actual earnings per share reported by Goldman Sachs Group Inc for the previous quarter, Wall Street now forecasts -22.72% negative EPS growth.

About 483,724 shares traded. GlycoMimetics Inc (GLYC) has risen 81.25% since June 20, 2016 and is uptrending. It has outperformed by 64.55% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 2 sales for $55,420 activity.

Bvf Inc Il holds 3.46% of its portfolio in GlycoMimetics Inc for 2.83 million shares. Nea Management Company Llc owns 8.58 million shares or 2.08% of their US portfolio. Moreover, Sphera Funds Management Ltd. has 1.15% invested in the company for 745,796 shares. The California-based Wall Street Associates has invested 0.6% in the stock. Cormorant Asset Management Llc, a Massachusetts-based fund reported 287,031 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: